Publisher Correction: Potentiating adoptive cell therapy using synthetic IL-9 receptors.
作者信息
Kalbasi Anusha, Siurala Mikko, Su Leon L, Tariveranmoshabad Mito, Picton Lora K, Ravikumar Pranali, Li Peng, Lin Jian-Xin, Escuin-Ordinas Helena, Da Tong, Kremer Sarah V, Sun Amy L, Castelli Sofia, Agarwal Sangya, Scholler John, Song Decheng, Rommel Philipp C, Radaelli Enrico, Young Regina M, Leonard Warren J, Ribas Antoni, June Carl H, Garcia K Christopher
机构信息
Department of Radiation Oncology, David Geffen School of Medicine and Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, USA.
Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.
出版信息
Nature. 2022 Dec;612(7938):E10. doi: 10.1038/s41586-022-05548-6.
Abstract
摘要
相似文献
1
Publisher Correction: Potentiating adoptive cell therapy using synthetic IL-9 receptors.
Nature. 2022 Dec;612(7938):E10. doi: 10.1038/s41586-022-05548-6.
2
Whole blood interferon-γ levels predict the therapeutic effects of adoptive T-cell therapy in patients with advanced pancreatic cancer.
Int J Cancer. 2013 Sep 1;133(5):1119-25. doi: 10.1002/ijc.28117. Epub 2013 Mar 29.
3
A potent vaccination strategy that circumvents lymphodepletion for effective antitumor adoptive T-cell therapy.
Cancer Res. 2012 Apr 15;72(8):1986-95. doi: 10.1158/0008-5472.CAN-11-3246. Epub 2012 Feb 24.
4
IL-27 improves adoptive CD8 T cells' antitumor activity via enhancing cell survival and memory T cell differentiation.
Cancer Sci. 2022 Jul;113(7):2258-2271. doi: 10.1111/cas.15374. Epub 2022 May 18.
5
Adoptive transfer of CD4+ T cells specific for subunit A of Helicobacter pylori urease reduces H. pylori stomach colonization in mice in the absence of interleukin-4 (IL-4)/IL-13 receptor signaling.
Infect Immun. 2001 Mar;69(3):1714-21. doi: 10.1128/IAI.69.3.1714-1721.2001.
6
Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy.
Clin Immunol. 2006 Apr;119(1):21-31. doi: 10.1016/j.clim.2005.11.003. Epub 2006 Jan 9.
7
Enhancing adoptive cancer immunotherapy with Vγ2Vδ2 T cells through pulse zoledronate stimulation.
J Immunother Cancer. 2017 Feb 21;5:9. doi: 10.1186/s40425-017-0209-6. eCollection 2017.
8
Publisher Correction: The transcription factor c-Maf is essential for the commitment of IL-17-producing γδ T cells.
Nat Immunol. 2019 May;20(5):663. doi: 10.1038/s41590-019-0349-6.
9
Kappa-opioid potentiation of tumor necrosis factor-alpha-induced anti-HIV-1 activity in acutely infected human brain cell cultures.
Biochem Pharmacol. 1998 Aug 1;56(3):397-404. doi: 10.1016/s0006-2952(98)00161-0.
10
IL-15 Upregulates Telomerase Expression and Potently Increases Proliferative Capacity of NK, NKT-Like, and CD8 T Cells.
Front Immunol. 2021 Jan 18;11:594620. doi: 10.3389/fimmu.2020.594620. eCollection 2020.
引用本文的文献
1
Adoptive neoantigen-reactive T cell therapy: improvement strategies and current clinical researches.
Biomark Res. 2023 Apr 17;11(1):41. doi: 10.1186/s40364-023-00478-5.
Zotero 插件